Increased Oxidative Stress Induced by Rubus Bioactive Compounds Induce Apoptotic Cell Death in Human Breast Cancer Cells

Abstract EN

Bioactive compounds from plants represent good candidate drugs for the prevention and treatment of various forms of cancer.

Berries are rich sources of bioactive compounds, and there has been an increasing interest in the study of therapeutic action of wild berries.

Oxidants are generated continuously in biological system as a result of physiological process.

When there is an imbalance between oxidants and antioxidants, it leads to a condition called oxidative stress.

Natural compounds as inducers of oxidative stress are able to modulate the physiological functions of cancer cells leading to cell death or survival.

The aim of this study was to evaluate the induction of apoptosis by isolated bioactive compounds (1-(2-hydroxyphenyl)-4-methylpentan-1-one (C1) and 2-[(3-methylbutoxy) carbonyl] benzoic acid (C2)) from Rubus fairholmianus against MCF-7 breast cancer cells.

The exposure of C1 and C2 reduced viability (IC50 of C1: 4.69; C2: 8.36 μg/mL) and proliferation.

Cytochrome c release from mitochondria and changes in mitochondrial membrane potential of treated cells supported the intrinsic apoptotic cell death.

Reactive oxygen species (ROS) production after treatment with C1 and C2 was found to be higher and induced nuclear damage.

Expression of apoptotic proteins after the treatments was significantly upregulated as indicated using immunofluorescence (caspase 9, p53, and Bax), western blotting (p53, cleaved PARP, cytochrome c, and Bax), and ELISA (caspase 9) analysis.

Overall, C1 was more cytotoxic, increased the ROS production in dichlorodihydrofluorescein diacetate assay, and induced apoptosis in breast cancer cells.

These results illustrate that berry bioactive compounds have strong chemopreventive potential.

In this article, we provide information on prooxidant and anticancer activities of Rubus bioactive compounds.

Natural products have always demonstrated a significant contribution to the development of several cancer chemotherapeutic drugs.

Most of these compounds are known to affect the redox state of the cell; and studies on these compounds have focused on their antioxidant property instead of prooxidant properties.